Key Metrics
CiteScore 

1.2
Impact Factor 

< 5
SJR 

Q4Biophysics

SNIP 

0.31
Recommended pre-submission checks
Powered by 

Topics Covered on Current Pharmaceutical Analysis
Current Pharmaceutical Analysis Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2005 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Pharmaceutical Analysis ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Current Pharmaceutical Analysis
Astragaloside IV Alleviates Peritoneal Dialysis-Related Peritoneal Fibrosis by Regulating HIF-1α-Mediated Autophagy
- 1 Oct 2026
- Current Pharmaceutical Analysis
Novel dichloroacetamide derivatives: Synthesis, cytotoxicity evaluation, molecular docking study, MD simulations, and ADME study
- 1 Oct 2026
- Current Pharmaceutical Analysis
A novel stability indicating LC method for simultaneous determination of Vildagliptin and Pioglitazone hydrochloride in API and marketed formulations
- 1 Oct 2026
- Current Pharmaceutical Analysis
Network pharmacology and molecular docking reveal the active compounds and key targets of JiaWei SiNi San in hepatocellular carcinoma
- 1 Oct 2026
- Current Pharmaceutical Analysis
Refining sedation strategies in elderly patients: A critical analysis of esketamine and propofol combination in gastrointestinal endoscopy
- 1 Oct 2026
- Current Pharmaceutical Analysis
Applications of QSPR polynomial and empirical models for predicting physicochemical properties of pharmaceutically important compounds
- 1 Oct 2026
- Current Pharmaceutical Analysis
Astragaloside IV Alleviates Peritoneal Dialysis-Related Peritoneal Fibrosis by Regulating HIF-1α-Mediated Autophagy
- 1 Oct 2026
- Current Pharmaceutical Analysis
Novel dichloroacetamide derivatives: Synthesis, cytotoxicity evaluation, molecular docking study, MD simulations, and ADME study
- 1 Oct 2026
- Current Pharmaceutical Analysis
A novel stability indicating LC method for simultaneous determination of Vildagliptin and Pioglitazone hydrochloride in API and marketed formulations
- 1 Oct 2026
- Current Pharmaceutical Analysis
Network pharmacology and molecular docking reveal the active compounds and key targets of JiaWei SiNi San in hepatocellular carcinoma
- 1 Oct 2026
- Current Pharmaceutical Analysis
Refining sedation strategies in elderly patients: A critical analysis of esketamine and propofol combination in gastrointestinal endoscopy
- 1 Oct 2026
- Current Pharmaceutical Analysis
Applications of QSPR polynomial and empirical models for predicting physicochemical properties of pharmaceutically important compounds
- 1 Oct 2026
- Current Pharmaceutical Analysis